LipiGo: A Versatile DNA-Lipid Nanoparticle Hybrid for Precision Drug Delivery
Kadletz, K.; Kimna, C.; Reichenbach, V. K.; Carofiglio, O.; Jeridi, D.; Hu, S.; Khalin, I.; Grzejdak, J.; Chen, Y.; Horvath, I.; Minde, D.-P.; Ali, M.; Sych, T.; Hoeher, L.; Aydeniz, E.; Kulcu, Y. A.; Ricci, A.; Liesz, A.; Sezgin, E.; Ussar, S.; Hellal, F.; Elsner, M.; Erturk, A.
Show abstract
Lipid nanoparticles (LNPs) are established carriers for nucleic acid delivery, however, achieving efficient delivery to non-hepatic tissues remains a major challenge. Here, we present LipiGo, a nanocarrier platform engineered by integrating short single stranded DNA molecules into the lipid nanoparticle structure. Using whole body tissue clearing, advanced imaging and AI-based analysis, we show that LipiGo redirects functional mRNA delivery to lymphoid organs, particularly the spleen. Immune cell profiling further reveals enhanced uptake within key immune populations, including antigen-presenting cells, compared to standard LNPs. Beyond passive redistribution, LipiGo leverages DNA hybridization to enable modular attachment of targeting ligands for active targeting as demonstrated by cell-specific delivery to white adipocytes. Overall, the dual-purpose design principle of LipiGo demonstrates high modularity and efficiency, enabling tissue and cell specific delivery beyond hepatic applications. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=100 SRC="FIGDIR/small/676334v2_ufig1.gif" ALT="Figure 1"> View larger version (45K): org.highwire.dtl.DTLVardef@9b69eorg.highwire.dtl.DTLVardef@1b45bd0org.highwire.dtl.DTLVardef@1f7b79dorg.highwire.dtl.DTLVardef@37a673_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- TLR7 and RIG-I dual-adjuvant loaded nanoparticles drive broadened and synergistic responses in dendritic cells in vitro and generate unique cellular immune responses in influenza vaccination 96%
- Hydroxychloroquine-functionalized Ionizable Lipids Mitigate Inflammatory Responses in mRNA Therapeutics 96%
- Advanced Peptide Nanoparticles Enable Robust and Efficient delivery of gene editors across cell types 96%
Similar papers in this journal
Similar papers in this journal
- Rapid precision targeting of nanoparticles to lung via caveolae pumping system in endothelium 96%
- Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability 95%
- DNA storage in thermoresponsive microcapsules for repeated random multiplexed data access 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.